In 1993, BTK was identified as the gene defective in X-linked agammaglobulinemia (XLA), an inherited immunodeficiency disease in humans characterized by a drastic deficiency in B lymphocytes, low levels of immunoglobulin (Ig), and recurring infections [34–37]. This evidence concerns the gene BTK and isolated agammaglobulinemia.